Seeking Alpha

freefdawatchlist's  Instablog

Send Message
Premium Service for Equity Trader.
My blog:
Premarket Trading Ideas
View freefdawatchlist's Instablogs on:
  • Basic Trading Technique Tip #1: MTRX Day Trade

    Whenever stock is down over 10, 20 or 30% , first thing investor think it should be easy to make 1-2% on such a weak. But sometime stocks that is down 10% goes further lower and end up 20% down at the close. As a day trader we focus on right entry and right exit point. Below I will be sharing very basic trading technique that's easy to understand.

    This was the trade that was executed after market open.

    (click to enlarge)
    Whats so special about this entry ?

    Step 1: Decide the stock to trade. In this example I'll explain MTRX trade.

    MTRX : missed earning and guided low and so it Gapped lower.

    (click to enlarge)
    MTRX chart at the open

    Step 2: Draw a horizontal line at the lower low of the bar as shown in the chart below and check if the next bar can cross the lower low level. If yes thats the right enty and if no then continue drawing line as shown in step 3.

    (click to enlarge)

    Step 3: Continue drawing horizontal line till the stock crosses the lower low level

    (click to enlarge)

    Step 4: At some point stock will find support and it will cross the lower low level which is Tweezer bottom and perfect entry point. Remember the moto is "Make small gain and move on" as shown in the chart below. The horizontal line becomes new support and resistance for the stock.

    (click to enlarge)

    Look for Tweezer top for reversal and Tweezer bottom for reversal bounce play.

    I hope this simple technique will be useful. Join us to learn more such simple technique which works.

    Tags: MTRX
    Sep 05 12:27 AM | Link | Comment!
  • Weekly Outlook For September 1st - 5th: CONN, GWRE, NAV, GIII, PVH, HRB, AVAV, MFRM, CIEN, HOV, PAY, MBLY, FNSR, BLOX, SEAC

    This week's top 20 % gainers

    • Technology: PSMI (12.45 +61.64%), MOBL (11.59 +33.97%)
    • Services:THI (80.44 +31.37%),TA (11.39 +18.29%),BKW (32.04 +16.65%)
    • Healthcare: RPRX (21.92 +41.79%), ITMN (73.45 +37.59%), FOLD (7.19 +34.38%), KITE (28.27 +23.8%), ACHN (11.57 +20.91%), IG (6.89 +18.5%), AXDX (20.26 +18.47%), CUR (4.07 +17.94%), ISIS (40.76 +16.77%), BDSI (16 +16.42%)
    • Financial: HGSH (7.53 +35.18%)
    • Conglomerates: REX (106.83 +17.48%)
    • Basic Materials: EMES (144.17 +17.03%)

    This week's top 20 % losers

    • Utilities:EDN (10.32 -9.07%)
    • Technology:QIHU (87.83 -13.08%),GRUB (38.44 -10.98%),YGE (3.36 -9.02%),SLH (60.96 -8.43%),WUBA (41.65 -7.81%),WIX (16.42 -7.78%)
    • Services:NDLS (19.57 -11.38%),BOBE (43.42 -10.38%),MEG (15.41 -10.24%),CTCT (31.17 -9.52%),WSM (65.77 -9.17%),SKYW (8.97 -9.1%),HUBG (43.49 -7.9%),
    • Industrial Goods:SWHC (11.07 -13.8%)
    • Healthcare:NVDQ (13.07 -14.04%)
    • Consumer Goods:MOV (37.13 -15.21%),TOUR (18.5 -13.07%),ZQK (2.91 -10.94%)
    • Basic Materials:MCP (1.79 -10.77%)

    Tuesday, September 2nd:

    Pre Market Earning - CONN, KFX

    After Hours Earning: - PIKE, GWRE, AVNW, PRGN

    Economic calendar:


    • Australian rate decision: Tuesday, 12:30 am EST: Australia's central bank maintained the cash rate at a record low of 2.5%, saying the nation's economic outlook remains unclear. The slowdown in mining investment weighs on growth. Therefore, GDP expansion in the June quarter is expected to be weaker than in the previous quarter. Domestic demand is also subdued due to elevated currency. However, lenient monetary policy boosted the housing market. Global issues also contributed to uncertainty tensions in Ukraine and Gaza and the guessing game around the timing of the first rate increase in the US. No change in rats is expected now.
    • US ISM Manufacturing PMI: Tuesday, 10:00 am EST: The U.S. manufacturing sector improved strongly in July reaching 57.1 points following 55.3 points in June. Economists expected a reading of 56.1. US Manufacturing remained in expansion territory for 14 consecutive months. New orders advanced to 63.4, rising 4. points from June's reading of 58.9. Production edged up to 61.2, from 60 and the employment soared to 58.2, up 5.4 points from June's reading of 53. A slight drop to 57 is forecasted this time.
    • Australian GDP: Wednesday, 9:30 pm EST:. Australia's economy expanded 1.1% in the first quarter beating expectations for a 0.9% growth rate. The high rise was explained by the unexpected growth to the mining, financial and insurance services and the construction boom. The rate of expansion in the last 12 months to March reached 3.5% indicating the economy is resilient. The RBA projects a growth rate of 2.75% for this year and a rise of 2.5% for 2015. Australia's economy is predicted to expand 0.4% in the second quarter.

    Wednesday, September 3rd:

    Pre Market Earning - NAV, TOL, GIII, VNCE, EGAN

    After Hours Earning - PVH, ABM, MTRX, DDC, SCVL, HRB, CBK, AVAV, BV

    Economic calendar:


    • Canadian rate decision: Wednesday, 10:00 am EST: Canada's central bank maintained its overnight rate target at 1% as it had been since September 2010. The Bank of Canada said global economic growth was subdued until April Monetary Policy Report, but is expected to pick up in the following months. In light of the lukewarm global outlook, Canada's GDP is expected to be weaker than previously expected. However, the softer Canadian dollar and forecast for increases in global demand, are expected to expand exports leading to higher growth rate. Real GDP growth in Canada was expected to average around 2 ¼ % in 2014-16. Rates are expected to remain unchanged.

    Thursday, September 4th:



    Economic calendar:


    • Rate decision in Japan: Thursday. The Bank of Japan kept its record stimulus measures to increase the monetary base at an annual pace of 60 trillion yen to 70 trillion yen, after weak releases of production and export data. Exports weakened in June as well as retail sales. Japan's economy shrank at an annual pace of 6.8% in the second quarter due to by a sales tax hike introduced in April and GDP contracted 1.7% from the first quarter.
    • Rate decision in the UK: Thursday, 7:00 am EST:. Bank of England policymakers decided to leave interest rates at 0.5% in their August meeting, however, for the first time in three years, two members unexpectedly voted to tighten policy and raise interest rates to 0.75%. The BoE lowered its forecasts for wage growth for 2014 saying it did not want to raise rates until stronger wage rises occur despite a decline in the unemployment rate which may lead to wage growth. Most of the MPC members said the inflation outlook was too weak to justify a rate hike despite a positive growth rate forecast in 2014.No change is expected now.
    • Rate decision in the Eurozone: Thursday 11:45, press conference at 12:30. Mario Draghi dropped the bomb in Jackson Hole, by acknowledging that low inflation is not only temporary, and that inflation expectations are falling. This raises expectations for action in September's meeting. However, Draghi is likely to look for a wider consensus, especially from his German colleagues. In addition, the TLTROs come into effect this month, and this could lead the governing council to wait. Thenot too horrible inflation numbers are also a reason to wait now. Nevertheless, we can expect heavier hints about QE and more pressure to keep the euro down, if not even lower. Some also expect another rate cut, but this is unlikely now. Draghi's words are set to rock the markets.
    • US ADP Non-Farm Employment Change: Thursday, 8:15 am EST:. U.S. employers hired 218,000 workers in July, posting the fourth months of private job growth beyond 200,000. However July's reading was lower than the 234,000 reading anticipated by analysts and considerable bellow June's rise of 281,000. Economists believe the economy will return to full employment by late 2016 if the pace of growth continues. Jobs in professional and business services increased by 61,000 in July, down from 79,000 in June, while positions in the trade, transportation and utilities category grew by 52,000 versus 56,000 in June. An addition of 216,000 jobs is expected now.
    • US Trade Balance: Thursday, 8:30 am EST: The U.S. trade deficit narrowed in June to its lowest level since January contracting to a seasonally adjusted $41.5 billion, from $44.7 billion in May. The improvement occurred due to a fall in imports, led by lower shipments of cellphones, petroleum, and cars. Exports climbed 0.1% to $195.9 billion, a record high. While imports fell 1.2%, the most in a year, to $237.4 billion. The unexpected drop implies that growth was stronger in the second quarter than initially estimated. Americans are buying more U.S. products, increasing economic expansion. The economy grew at a 4% annual rate in the second quarter, but this estimate included higher trade deficit than was eventually registered in June. The U.S. trade deficit is expected to reach 42.5.
    • US Unemployment Claims: Thursday, 8:30 am EST:The number of Americans applying for unemployment benefits declined by 1,000 last week to a seasonally adjusted 298,000, indicating fewer layoffs and strong hiring. The four-week average, a less volatile measure, fell to 299,750. Employers are more confident in the economy therefore reduce dismissals. Employers added an average of 230,000 jobs a month this year, above the average of 195,000 in 2013. Average job gains since February have been the best in eight years. The number of jobless claims is expected tro increase by 298,000 this week.
    • US ISM Non-Manufacturing PMI: Thursday, 10:00 am EST: Service sector activity in the U.S. soared in July to 58.7 from a reading of 56.0 in June, rising at the fastest rate in more than three years. The reading was better than the 56.6 estimated by analysts, suggesting a growth trend in the US economy and a positive outlook for the coming months. The Non-Manufacturing Business Activity Index climbed to 62.4, from 57.5 posted in June, The New Orders Index registered 64.9, from 61.2 registered in June. The Employment Index edged up 1.6 points to 56 from the June reading of 54.4 and indicates growth for the fifth consecutive month. Service sector activity is expected to decline to 57.3.

    Friday, September 5th:

    Economic Calendar:


    • Canadian employment data: Friday, 8:30 am EST: Canadian job market rebounded in July with a 42,000 job increase, following a 10,000 decline in the previous month. The reading nearly doubled estimates for a 25,400 job addition. July's labor market figures were distorted by an "isolated incident" due to "human error" at Statistics Canada. Meanwhile, the unemployment rate declined to 7% in July, from 7.1% reading in the previous month. Canada's workforce is expected to expand by 10,300 positions while the unemployment rate is predicted to remain at 7%.
    • US Non-Farm Payrolls and Unemployment rate: Friday, 8:30 am EST: US nonfarm payrolls edged up 209,000 in July after an upwardly revised increase of 298K in June. The reading was worse than the 231,000 rise projected by analysts. However job growth remained above 200,000 in the last six months. The unemployment rate edged up to 6.2% from 6.1% a month earlier, due to an increase in the labor force. US nonfarm payrolls is expected to gain 222,000 jobs while the unemployment rate is expected to decline to 6.1%.

    Aug 30 1:45 PM | Link | Comment!
  • Upcoming FDA Approvals For September - October 2014: KERX, NPSP, SLXP, MDVN, PSDV, GILD, PCYC, NVS, AUXL, REGN, NPSP

    Below are the list of companies waiting for FDA approval. Here is a guideline you should keep in mind while buying /shorting this stocks.

    • If a stocks get FDA approval, it jumps 30-40% easily.
    • If the market cap is below 1B and FDA denies or give complete response letter then the stocks falls down by 30-40%. For market cap above 5 -10B, there is movement of up or down by 2%.
    • Buying activity in stock starts 3-4 month ahead of FDA decision. Selling activity starts after 3 days of approval.
    • If FDA panel decision doesn't back up drug, it will fall. After FDA panel decision, official approval from FDA comes within 1 month.
    • If FDA panel back any stock, it will keep rising till it gets final decision. On final decision date, if stock get approval, stock rises in the morning and then it falls.
    • On receiving complete response, stocks falls and keep falling for atleast 15 -20 days. Buying activity starts after 15 days on anticipation that company will resubmit for FDA approval.

    09/07/2014 Keryx Biopharmaceuticals Inc (KERX):
    FDA decision on Zerenex for the treatment of hyperphosphatemia in dialysis-dependent chronic kidney disease (CKD) patients

    09/12/2014 NPS Pharmaceuticals Inc (NPSP):
    FDA panel to review Natpara for the treatment of hypoparathyroidism

    09/15/2014 Salix Pharmaceuticals Ltd (SLXP):
    FDA decision on Budesonide 2 mg Rectal Foam for the induction of remission in patients with active mild to moderate distal ulcerative colitis

    09/18/2014 MEDIVATION INC (MDVN):
    FDA decision on XTANDI for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC) who have not received chemotherapy

    09/26/2014 pSivida Limited (PSDV):
    FDA decision on ILUVIEN for treatment of Diabetic Macular Edema

    10/03/2014 Gilead Sciences Inc. (GILD):
    FDA decision on Cobicistat as a boosting agent for HIV therapy

    10/04/2014 Gilead Sciences Inc. (GILD):
    FDA decision on Elvitegravir or the treatment of HIV-1 infection in treatment-experienced adults

    10/07/2014 Pharmacyclics Inc. (PCYC):
    FDA decision on IMBRUVICA in the treatment of patients with chronic lymphocytic leukemia and small lymphocytic lymphoma who have received at least one prior therapy for a full approval.

    10/10/2014 Gilead Sciences Inc. (GILD):
    FDA decision on Ledipasvir/Sofosbuvir for chronic hepatitis C genotype 1 infection

    10/20/2014 Novartis AG (NVS):
    FDA panel to review Secukinumab for the proposed treatment of moderate to severe plaque psoriasis

    10/20/2014 Auxilium Pharmaceuticals Inc. (AUXL):
    FDA decision on XIAFLEX for the treatment of two Dupuytren's contracture (DC) cords concurrently

    10/23/2014 Regeneron Pharmaceuticals (REGN):
    FDA decision on EYLEA for the expanded indication of of Macular Edema following Branch Retinal Vein Occlusion

    10/24/2014 NPS Pharmaceuticals Inc (NPSP):
    FDA decision on Natpara for the treatment of hypoparathyroidism

    Aug 24 3:42 PM | Link | Comment!
Full index of posts »
Latest Followers


More »

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.